↓ Skip to main content

Dove Medical Press

Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome

Overview of attention for article published in Therapeutics and Clinical Risk Management, August 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
107 Mendeley
Title
Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome
Published in
Therapeutics and Clinical Risk Management, August 2014
DOI 10.2147/tcrm.s65066
Pubmed ID
Authors

Naoki Aikawa, Yasushi Kawasaki

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 107 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 16%
Student > Ph. D. Student 14 13%
Student > Bachelor 9 8%
Student > Master 8 7%
Student > Doctoral Student 8 7%
Other 25 23%
Unknown 26 24%
Readers by discipline Count As %
Medicine and Dentistry 25 23%
Agricultural and Biological Sciences 10 9%
Nursing and Health Professions 9 8%
Immunology and Microbiology 9 8%
Biochemistry, Genetics and Molecular Biology 7 7%
Other 19 18%
Unknown 28 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2022.
All research outputs
#8,534,976
of 25,373,627 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#78,829
of 240,206 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 15 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,206 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.